Matthew Woolard, PhD, Professor of Microbiology and Immunology, is the Principal Investigator awarded a $2.2M 4-year ROI grant by the National Institute of Health.
Faculty, staff and students at LSU Health Shreveport are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology, neuroscience, addiction and immunology. A core part of the institution’s mission, research on campus ranges from basic science to translational research and testing the latest therapies in clinical trials. The School of Graduate Studies helps to train future scientists, and our six centers, four of which are Louisiana Board of Regents recognized Centers of Excellence, further elevate our research portfolio.
The Office of the Vice Chancellor for Research supports these endeavors and is comprised of the Office for Sponsored Programs and Technology Transfer, Research Development and Management, Human Research Protections Program (HRPP), the Institutional Review Board (IRB), and the Research Core Facility.
Research by the NUMBERS
TOTAL Federal Grant Funding (FY21-22)
↑ 300% increase in grant funding since FY15
Technology Transfer (FY20-21)
Invention Disclosures: 32
Patents Filed: 421 l Patents Issued: 8 U.S. / 1 Foreign
Licenses and Options: 6
Total Licensing Income: $519,000
Ranked 2nd in the LSU System for tech transfer
RECENT RESEARCH AWARDS
Hui-Chao (Reggie) Lee, PhD, LSUHS Assistant Professor of Neurology, is the Principal Investigator on a 3-Year Transformational Project Award funded by the American Heart Association for $300,000.
Jeremy Kamil, PhD, Associate Professor of Microbiology and Immunology, is the Principal Investigator awarded a $2M 5-year ROI competing continuation grant by the National Institute of Health.
Hong Sun, MD, PhD, Associate Professor of Cellular Biology and Anatomy, was awarded a $1.8M 5-year R01 competing continuation grant from the NIH National Institute on Alcohol Abuse and Alcoholism.
Krista Rodgers, PhD, was recently awarded an NIH RO1 grant entitled “Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions” from the National Institute of Neurological Disorders and Stroke.
Art Yurdagul, PhD, Assistant Professor of Molecular and Cellular Physiology, was awarded a $2.8M 5-year ROI Grant by the National Institutes of Health's National Heart, Lung, and Blood Institute.
Nirav Dhanesha, PhD, Assistant Professor of Pathology and Translational Pathobiology, received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute for his project “Mechanisms for Deep Vein Thrombosis following Stroke.”
Oren Rom, PhD, RD, Assistant Professor of Pathology and Translational Pathobiology, has been awarded a 5-year, $1.6 million R01 grant from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for his project, “Lipidated Amino Acids in Cardiometabolic Diseases.”
The Center for Redox Biology and Cardiovascular Disease CoBRE at LSU Health Shreveport, led by Principal Investigator Chris Kevil, PhD, was awarded a $730,000 supplement award from the NIH’s National Institute of General Medical Sciences (NIGMS) for “SARS-CoV-2 Genomic Surveillance in North Louisiana.”
School of Graduate Studies student Brenna Pearson-Gallion was awarded a F31 Pre-Doctoral Fellowship from the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) for her project “EphA2 in Non-Alcoholic Fatty Liver Disease”.
Chris Kevil, PhD, Vice Chancellor for Research at LSU Health Shreveport, was awarded a 4-year NIH R01 grant for $1.7 million from the National Heart, Lung and Blood Institute for his project, “CSE regulation of vascular remodeling.”
Dr. Arrigo DeBenedetti receives Spring 2021 Feist Weiller Cancer Center (FWCC) Bridging Award grant in the amount of $100,000.
Diana Cruz, PhD, Assistant Professor, joined the LSUHS Department of Molecular and Cellular Physiology in July 2016. Her current research looks at the interface between the endocrine and cardiovascular systems, emphasizing the effects of stress signaling (glucocorticoid receptors) on cardiovascular health.
Dr. Sushil Jain, a Professor in the Department of Pediatrics at LSU Health Shreveport, has been awarded a 3-year, $1.52 million grant from the National Institutes of Health (NIH) for a project entitled: Optimization of 25-hydroxy-vitamin D levels in African Americans.
Dr. David Gross, a professor in the Department of Biochemistry and Molecular Biology at LSU Health Shreveport, has been awarded a 4-year, $1.2 million grant from the National Institutes of Health for a project entitled “Genome Architecture and Gene Control in Response to Stress.”
LATEST NEWS HIGHLIGHTS
Five new patents have been awarded to current or retired LSU Health Shreveport faculty members in fiscal year 2024. These patents not only protect the intellectual property of the inventors but offer new processes or treatment methods options that significantly advance science and medical care.
On Thursday, February 15, LSU Health Shreveport Office for Research celebrated their successes of the previous year, including more than $23 million in extramural funding and 100+ clinical trials.
Congratulations to our students and postdocs who received a total of $573,940 in American Heart Association awards.
KTBS3 - LSUHS is one of only 25 sites around the country participating in a major clinical trial for individuals with stiff heart syndrome. About half of of patients with heart failure suffer from a stiff heart muscle.
On Monday, December 11, Gov. John Bel Edwards joined officials with LSUHS to unveil the transformative Center for Medical Education, the first new building on the campus since 2008. More than 400 invited guests joined LSU and LSUHS leadership to celebrate the completion of the four-story, 155,000-square-foot, $79 million structure.
Newswise - “We are very enthusiastic about implementing Dimensions Analytics and Dimensions Research Security to support our research data and analysis needs, as well as improve efficiency regarding research integrity and compliance,” said Jarrod Sawyer, LSUHS Research Data and Applications Project Manager.
LSU Health Shreveport / Feist-Weiller Cancer Center is a strategic partner with MD Anderson and the Cancer Focus Fund LP working to advance promising cancer therapies.
“BRAID is more than just a conference, it’s a vibrant ecosystem of ideas fostering innovation among students, scientists and clinicians,” said Wayne Nix, chief innovation officer at LSUHS. “We celebrate the great minds of academia and industry brought together for a collaborative effort from all of our partners."
Louisiana Economic Development - LSU Health Shreveport scientists have discovered a promising new treatment for prostate cancer and developed a playbook detailing how to track viral variants in underserved areas.